BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Aging
    • Biosimilars
      • Artificial intelligence
    • Coronavirus
    • Israel
    • IVDs on the rise
    • Radiopharmaceuticals
    • Rise of obesity
    • Science '22 in Review
    • Top Biopharma Trends of 2022
    • Top Med-tech Trends of 2022
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • sign in
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, December 11, 2023
Home » Blogs » BioWorld MedTech Perspectives » Elekta provides LINC to innovation

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

BioWorld MedTech

Elekta provides LINC to innovation

Nov. 11, 2013
By Omar Ford
No Comments

The first thing that hits you when you walk in Elekta's Learning and Innovation Center (LINC) located in Atlanta, is that there is a lot of history here.

Elekta3

From the Leksell Stereotactic System invented in 1949, to the Leskell Gamma Knife Perfexion - the advances in med-tech through the lens of a once small but now sizeable company are evident.

But to merely think of this as a repository of the firm's greatest technological achievements and advancements in the treatment of cancer would be egregiously wrong. LINC is a learning center that links the past to future innovation.

DSCN0013The 25,000 square foot facility that boasts lecture rooms and all of the firm's latest technology is instead a learning destination. LINC was launched during the American Society for Radiology (Fairfax, Virginia) meeting held in Atlanta in September. Last month, Medical Device Daily toured the facility, which boasts some of the companies flagship technology, such as the new Versa HD linear accelerator and Leksell Gamma Knife Perfexion. Enhancing the experience, students have access to the Versa HD vault, which is large enough for hands-on learning. Elektaphoto1

"Elekta's really putting forward education and training for patient safety as a first priority," Ian Dickson, Elekta's CFO, told Medical Device Daily. "The company has grown so rapidly in the last four or five years – there's been a lot of organic growth but also through acquisition. Our education programs are pretty dispersed around the U.S. so we saw this to really get the value proposition and to put safe training and education on the map for us as an organization into the radiation community we needed to centralize it, and that's what we did by bringing it here into the Perimeter area here in Atlanta."

Elekta4Simply put, Elekta is on the right path to innovation. You can't go forward without investing in the future of your technology.  Giving healthcare professionals the advanced training that they might need on Elekta's wide array of products accomplishes that goal.

You must login or register in order to post a comment.

Report Abusive Comment

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 8, 2023.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for December 8, 2023.
  • Coronavirus, mRNA and syringe

    Off-target immune response from modified mRNA impacts future development

    BioWorld
    The Nobel Prize-winning modification that prevents the innate immune system from recognizing injected mRNA as foreign and blocking transcription of the protein it...
  • Stock chart with falling red arrow

    ‘Ridiculous’ site-based hitches mar Biovie phase III in Alzheimer’s

    BioWorld
    For the second time this week, a contract research organization has come under fire for trial-conduct issues – criticism leveled most recently by Biovie Inc.,...
  • Feet and scale

    Waging the losing battle: Altimmune takes on challengers as Pfizer falls back

    BioWorld
    Altimmune Inc.’s peptide-based glucagon-like peptide-1/glucagon dual receptor agonist pemvidutide hiccupped in a phase I study earlier this year but has bounced...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing